Liberty Star Uranium & Metals (LBSR) 10-Q 16 Dec 24 2025 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 31, 2024	Dec. 16, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Oct. 31, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--01-31
Entity File Number	000-50071
Entity Registrant Name	LIBERTY STAR URANIUM & METALS CORP.
Entity Central Index Key	0001172178
Entity Tax Identification Number	90-0175540
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2 East Congress Street Ste. 900
Entity Address, City or Town	Tucson
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85701
City Area Code	520
Local Phone Number	425-1433
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		51,945,913

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Oct. 31, 2024	Jan. 31, 2024
Current assets:
Cash and cash equivalents	$ 27,158	$ 72,099
Prepaid expenses and other current assets	21,188	14,356
Total current assets	48,346	86,455
Noncurrent assets:
Property and equipment, net	12,792	17,644
Deferred financing costs	20,000
Total noncurrent assets	32,792	17,644
Total assets	81,138	104,099
Current:
Accounts payable and accrued liabilities	238,151	165,212
Convertible promissory note, net of unamortized debt discount of $39,917 and $0	200,983	95,000
Derivative liability	637,477	2,547,458
Total current liabilities	2,014,848	3,134,498
Long-term:
Long-term debt - SBA, net of current portion	32,400	32,400
Total long-term liabilities	32,400	32,400
Total liabilities	2,047,248	3,166,898
Commitments and Contingencies
Stockholders’ deficit:
Class A common stock - $.00001 par value; 500,000 authorized; 500,000 shares issued and outstanding	5	5
Common stock - $.00001 par value; 149,500,000 authorized; 51,156,228 and 49,813,861 shares issued and outstanding, respectively	512	498
Additional paid-in capital	57,230,440	58,538,033
Subscription receivable	(101,100)	(117,850)
Accumulated deficit	(59,095,967)	(61,483,485)
Total stockholders’ deficit	(1,966,110)	(3,062,799)
Total liabilities and stockholders’ deficit	81,138	104,099
Related Party [Member]
Current:
Accrued expenses, related party	8,117
Advances, related party	185,000
Notes payable	736,598	326,828
Nonrelated Party [Member]
Current:
Notes payable	$ 8,522

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Oct. 31, 2024	Jan. 31, 2024
Convertible promissory note, unamortized debt discount	$ 39,917	$ 0
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	149,500,000	149,500,000
Common stock, shares issued	51,156,228	49,813,861
Common stock, shares outstanding	51,156,228	49,813,861
Common Class A [Member]
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	500,000	500,000
Common stock, shares issued	500,000	500,000
Common stock, shares outstanding	500,000	500,000

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Income Statement [Abstract]
Revenues
Expenses:
Geological and geophysical costs	42,300	112,104	409,987	125,792
Salaries and benefits	56,806	55,737	176,805	152,419
Professional services	46,691	33,904	189,092	121,437
General and administrative	133,693	49,422	441,751	127,851
Net operating expenses	279,490	251,167	1,217,635	527,499
Loss from operations	(279,490)	(251,167)	(1,217,635)	(527,499)
Other income (expense):
Interest expense	(83,932)	(88,680)	(180,785)	(209,984)
Other income	956	1,126	2,882	2,365
Gain on change in fair value of derivative liability	1,289,458	86,112	3,783,056	160,551
Total other income (expense)	1,206,482	(1,442)	3,605,153	(47,068)
Net income (loss)	$ 926,992	$ (252,609)	$ 2,387,518	$ (574,567)
Net income (loss) per share of common stock – basic	$ 0.02	$ (0.01)	$ 0.05	$ (0.02)
Net income (loss) per share of common stock - diluted	$ 0.02	$ (0.01)	$ 0.04	$ (0.02)
Weighted average shares outstanding - basic	50,794,090	32,289,211	50,193,594	24,676,301
Weighted average shares outstanding - diluted	61,601,303	32,289,211	62,349,267	24,676,301

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member] Common Class A [Member]	Common Stock [Member]	Subscription Receivable [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Jan. 31, 2023	$ 1	$ 186	$ (117,468)	$ 56,941,222	$ (57,403,227)	$ (579,286)
Balance, shares at Jan. 31, 2023	102,000	18,671,159
Cashless exercise of options		$ 3	(16,750)	16,747
Cashless exercise of options, shares		250,000
Stock based compensation				19,265		19,265
Net income ( loss)					(118,579)	(118,579)
Shares issued for conversion of notes		$ 13		70,930		70,943
Shares issued for conversion of notes, shares		1,251,270
Resolution of derivative liabilities due to debt conversions and untainted warrants				43,931		43,931
Receipt of subscription receivable			16,368			16,368
Balance at Apr. 30, 2023	$ 1	$ 202	(117,850)	57,092,095	(57,521,806)	(547,358)
Balance, shares at Apr. 30, 2023	102,000	20,172,429
Balance at Jan. 31, 2023	$ 1	$ 186	(117,468)	56,941,222	(57,403,227)	(579,286)
Balance, shares at Jan. 31, 2023	102,000	18,671,159
Net income ( loss)						(574,567)
Balance at Oct. 31, 2023	$ 3	$ 498	(117,850)	58,423,801	(57,977,794)	328,658
Balance, shares at Oct. 31, 2023	250,000	49,813,861
Balance at Apr. 30, 2023	$ 1	$ 202	(117,850)	57,092,095	(57,521,806)	(547,358)
Balance, shares at Apr. 30, 2023	102,000	20,172,429
Stock based compensation		$ 10		24,354		24,364
Net income ( loss)					(203,379)	(203,379)
Shares issued for conversion of notes		$ 17		61,078		61,095
Shares issued for conversion of notes, shares		1,690,073
Resolution of derivative liabilities due to debt conversions and untainted warrants				125,520		125,520
Stock based compensation, shares		978,300
Issuance of common stock and warrants in private placement		$ 35		159,965		160,000
Issuance of common stock and warrants in private placement, shares		3,542,778
Balance at Jul. 31, 2023	$ 1	$ 264	(117,850)	57,463,012	(57,725,185)	(379,758)
Balance, shares at Jul. 31, 2023	102,000	26,383,580
Stock based compensation				19,614		19,614
Net income ( loss)					(252,609)	(252,609)
Shares issued for conversion of notes		$ 27		101,215		101,242
Shares issued for conversion of notes, shares		2,725,574
Resolution of derivative liabilities due to debt conversions and untainted warrants				(11,241)		(11,241)
Issuance of common stock and warrants in private placement	$ 4	$ 205		851,201		851,410
Issuance of common stock and warrants in private placement, shares	398,000	20,454,707
Shares exchanged	$ (2)	$ 2
Shares exchanged, shares	(250,000)	250,000
Balance at Oct. 31, 2023	$ 3	$ 498	(117,850)	58,423,801	(57,977,794)	328,658
Balance, shares at Oct. 31, 2023	250,000	49,813,861
Balance at Jan. 31, 2024	$ 5	$ 498	(117,850)	58,538,033	(61,483,485)	(3,062,799)
Balance, shares at Jan. 31, 2024	500,000	49,813,861
Cashless exercise of options		$ 1		(1)
Cashless exercise of options, shares		70,002
Stock based compensation				77,626		77,626
Settlement of subscription receivable			16,750			16,750
Net income ( loss)					311,381	311,381
Balance at Apr. 30, 2024	$ 5	$ 499	(101,100)	58,615,658	(61,172,104)	(2,657,042)
Balance, shares at Apr. 30, 2024	500,000	49,883,863
Balance at Jan. 31, 2024	$ 5	$ 498	(117,850)	58,538,033	(61,483,485)	$ (3,062,799)
Balance, shares at Jan. 31, 2024	500,000	49,813,861
Cashless exercise of options, shares						75,000
Net income ( loss)						$ 2,387,518
Shares issued for conversion of notes, shares		867,389
Balance at Oct. 31, 2024	$ 5	$ 512	(101,100)	57,230,440	(59,095,967)	(1,966,110)
Balance, shares at Oct. 31, 2024	500,000	51,156,228
Balance at Apr. 30, 2024	$ 5	$ 499	(101,100)	58,615,658	(61,172,104)	(2,657,042)
Balance, shares at Apr. 30, 2024	500,000	49,883,863
Stock based compensation				173,569		173,569
Net income ( loss)					1,149,145	1,149,145
Shares issued for conversion of notes		$ 2		34,998		35,000
Shares issued for conversion of notes, shares		185,381
Resolution of derivative liabilities due to debt conversions and untainted warrants				17,739		17,739
Reclass of APIC to derivative liabilities for tainted warrants				(3,331,913)		(3,331,913)
Balance at Jul. 31, 2024	$ 5	$ 501	(101,100)	55,510,051	(60,022,959)	(4,613,502)
Balance, shares at Jul. 31, 2024	500,000	50,069,244
Stock based compensation		$ 2		106,133		106,135
Net income ( loss)					926,992	926,992
Shares issued for conversion of notes		$ 7		79,393		79,400
Shares issued for conversion of notes, shares		682,008
Resolution of derivative liabilities due to debt conversions and untainted warrants				34,737		34,737
Reclass of APIC to derivative liabilities for tainted warrants				1,473,714		1,473,714
Shares issued for cash, net		$ 1		6,413		6,414
Shares issued for cash, net, shares		79,976
Shares issued for deferred financing costs		$ 1		19,999		20,000
Shares issued for deferred financing costs, shares		100,000
Stock based compensation, shares		225,000
Balance at Oct. 31, 2024	$ 5	$ 512	$ (101,100)	$ 57,230,440	$ (59,095,967)	$ (1,966,110)
Balance, shares at Oct. 31, 2024	500,000	51,156,228

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 2,387,518	$ (574,567)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation	4,852	4,534
Stock based compensation	357,330	63,243
Amortization of debt discounts	112,835	197,477
Gain on change in fair value of derivative liabilities	(3,783,056)	(160,551)
Changes in assets and liabilities:
Prepaid expenses	17,438	8,544
Accounts payable and accrued expenses	77,339	37,017
Accrued expenses to related party	8,117
Cash flows used in operating activities:	(817,627)	(424,303)
Cash flows from financing activities:
Proceeds from advances, related party	210,000	1,363
Repayments of advances, related party	(25,000)
Proceeds from notes payable, related party	467,000	35,000
Repayment on notes payable, related party	(40,000)
Repayments on notes payable	(16,228)	(19,058)
Proceeds from convertible promissory notes	286,000	80,000
Repayments on convertible promissory notes	(115,500)
Proceeds from the issuance of common stock for cash, net	6,414
Proceeds from the issuance of common stock and warrants in a private placement		999,751
Receipt of subscription receivable		16,368
Net cash provided by financing activities	772,686	1,113,424
Increase (decrease) in cash and cash equivalents	(44,941)	689,121
Cash and cash equivalents, beginning of period	72,099	32,616
Cash and cash equivalents, end of period	27,158	721,737
Supplemental disclosure of cash flow information:
Income tax paid
Interest paid	948
Supplemental disclosure of non-cash items:
Resolution of derivative liabilities due to debt conversions and untainted warrants	52,476	156,309
Reclass of APIC to derivative liabilities for tainted warrants	1,858,199	1,901
Debt discounts due to derivative liabilities	67,352	146,368
Shares issued for conversion of debt and interest	114,400	233,280
Expenses paid by related party on behalf of the Company		21,828
Prepaid insurance financed with note payable	24,750	24,850
Cashless exercise of warrants		16,750
Settlement of subscription and interest receivable	17,230
Non-cash equipment addition		1,908
Non-cash payment on note payable, related party		9,751
Shares issued for deferred financing costs	$ 20,000

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended						9 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Apr. 30, 2024	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2024	Oct. 31, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ 926,992	$ 1,149,145	$ 311,381	$ (252,609)	$ (203,379)	$ (118,579)	$ 2,387,518	$ (574,567)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Oct. 31, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation

Basis of Presentation	9 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	NOTE 1 – Basis of Presentation The consolidated financial statements included herein have been prepared by Liberty Star Uranium & Metals Corp. (the “Company”, “we”, “our”) without audit, pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and should be read in conjunction with our annual report on Form 10-K for the year ended January 31, 2024 as filed with the SEC on May 15, 2024. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been omitted, as permitted by the SEC, although we believe the disclosures which are made are adequate to make the information presented not misleading. The consolidated financial statements reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position at October 31, 2024, and the results of our operations and cash flows for the periods presented. Interim results are subject to significant seasonal variations and the results of operations for the three and nine months ended October 31, 2024, are not necessarily indicative of the results to be expected for the full year.

Going Concern

Going Concern	9 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 2 – Going Concern The Company has a history of and expects to continue to report stockholders’ deficit, negative cash flows from operations and loss from operations. Additional funds are required for further exploratory activity and to maintain its claims prior to attaining a revenue generating status. There are no assurances that a commercially viable mineral deposit exists on any of our properties. In addition, the Company may not find sufficient ore reserves to be commercially mined. As such, there is substantial doubt about the Company’s ability to continue as a going concern. Management is working to secure additional funds through the exercise of stock warrants already outstanding, equity financing, debt financing or joint venture agreements. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3 – Summary of Significant Accounting Policies Fair Value Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) ASC 820 Fair Value Measurements and Disclosures Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services. Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort. Schedule of Fair Value of Financial Instruments Fair value measurements at reporting date using: Description Fair Value Quoted Significant Significant Warrant and convertible note derivative liabilities at October 31, 2024 $ 637,477 – – $ 637,477 Warrant and convertible note derivative liabilities at January 31, 2024 $ 2,547,458 – – $ 2,547,458 Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liabilities. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liabilities, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liabilities are reported in other income (expense) as gain (loss) on change in fair value of derivative liabilities. Net income (loss) per share Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Potential common stock equivalents are determined using the treasury stock method. For diluted net income (loss) per share purposes, the Company excludes stock options and other stock-based awards, including shares issued as a result of option exercises that are subject to repurchase by the Company, whose effect would be anti-dilutive from the calculation. During the three and nine months ended October 31, 2024, the impact of 1,525,386 1,743,667 9,281,827 10,412,006 0 0 2,099,941 3,450,319 A reconciliation of the weighted average shares outstanding used in basic and diluted earnings per share computation is as follows: Schedule of Reconciliation of Weighted Average Shares Outstanding 2024 2023 2024 2023 For the Three Months Ended For the Nine Months Ended October 31, October 31, 2024 2023 2024 2023 Basic income (loss) per common share Net income (loss) available to common shareholders $ 926,992 $ (252,609 ) $ 2,387,518 $ (574,567 ) Derivative (gain) loss associated with convertible debt (11,432 ) - (14,876 ) - Interest expense associated with convertible debt (5,142 ) - (16,415 ) - Net income (loss) for dilutive calculation $ 910,418 $ (252,609 ) $ 2,356,227 $ (574,567 ) Weighted average common shares outstanding 50,794,090 32,289,211 50,193,594 24,676,301 Dilutive effect of convertible debt - - - - Dilutive effect of common stock warrants 9,281,827 - 10,412,006 - Dilutive effect of common stock options 1,525,386 - 1,743,667 - Weighted average shares outstanding for diluted net income (loss) per share 61,601,303 32,289,211 62,349,267 24,676,301

Related Party Transactions

Related Party Transactions	9 Months Ended
	Oct. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 4 – Related Party Transactions Our CEO, Brett Gross, was elected as President and Chief Executive Officer on December 7, 2018. On September 29, 2023, Mr. Gross resigned from his position as President and Chief Executive Officer of the Company. Patricia Madaris, VP Finance and Chief Financial Officer will serve as the Interim Chief Executive Officer. Accrued Expenses As of October 31, 2024, and January 31, 2024, we had a balance of accrued unpaid vacation days of $ 8,117 0 Advances During the nine months ended October 31, 2024, the Company received advances of $ 210,000 25,000 185,000 Note payable On January 31, 2023, the Company entered into a promissory note with Brett Gross for $ 50,000 86,579 10 January 31, 2024 16,750 480 40,000 19,598 76,828 On January 25, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, for $ 250,000 10 January 25, 2025 On February 13, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $ 210,000 10 February 13, 2025 On April 3, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $ 75,000 10 April 3, 2025 On May 1, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $ 45,000 10 May 1, 2025 On May 20, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $ 67,000 10 May 20, 2025 On July 5, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $ 70,000 10 July 5, 2025 As of October 31, 2024, and January 31, 2024, the note payable related party balance was $ 736,598 326,828 Other On February 21, 2024, the Company received a notice to exercise 75,000 70,002 On June 28, 2024, the Company granted 337,501 ten years 0.226 76,275 0.226 0.226 10 178 4.36 0

Stockholders_ deficit

Stockholders’ deficit	9 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stockholders’ deficit	NOTE 5 – Stockholders’ deficit Common Stock Our common shares are all of the same class, are voting and entitle stockholders to receive dividends to the extent declared by the Board of Directors. Upon liquidation or wind-up, stockholders are entitled to participate equally with respect to any distribution of net assets. On July 3, 2024, the Board of Directors amended the articles of incorporation to increase the Company’s common stock by 75,000,000 Common Stock for Services On May 26, 2023, the Company entered into a twelve-month stock compensation and subscription agreement with an investor relations firm that includes the issuance of 978,300 978,300 12,229 On August 5, 2024, the Company entered into a twelve-month stock compensation and subscription agreement with an investor relations firm that includes the issuance of 225,000 45,000 45,000 Equity Financing On September 25, 2024, the Company entered into an investment agreement (the “Investment Agreement”) with GHS Investments, LLC (the “Investor”), whereby the Investor has agreed to invest up to $ 10,000,000 The amount that we shall be entitled to sell to Investor shall be equal to two hundred percent (200%) of the average daily volume (U.S. market only) of the common stock for the ten (10) trading days prior to the applicable notice date so long as such amount does not exceed a calculated dollar amount per every 10 days of $500,000. The minimum amount shall be equal to $10,000. 79,976 6,414 0.08 100,000 20,000 1,000 20,000 Shares Issued for Conversion of Notes During the nine months ended October 31, 2024, the Company issued a total of 867,389 110,000 4,000 0.0961 0.1888 Subscription Receivable On September 29, 2022, the Company granted 674,000 ten years 0.15 104,226 101,100 674,000 3.15 September 30, 2027 On March 13, 2023, the Company granted 250,000 ten years 0.067 16,750 16,750 250,000 3.15 March 15, 2028 16,750 480 As of October 31, 2024, and January 31, 2024, the subscription receivable was $ 101,100 117,850 Stock Options Qualified and non-qualified incentive stock options outstanding at October 31, 2024 are as follows: Schedule of Stock Option Activity Number of Weighted Outstanding, January 31, 2024 2,808,760 $ 0.83 Granted 632,238 0.22 Expired – – Exercised (75,000 ) 0.05 Outstanding, October 31, 2024 3,365,998 $ 0.74 Exercisable, October 31, 2024 3,203,498 $ 0.76 These options had a weighted average remaining life of 9.11 253,984 0.178 On December 4, 2023, the Company entered into a letter of understanding with a geologist for services to be provided to the Company. As compensation, the Company will pay $ 4,000 10,000 4,000 three years 54,000 0.047 0.725 15,024 15,024 On June 28, 2024, the Company granted 165,737 ten years 0.226 37,457 0.226 0.226 10 178 4.36 0 On August 23, 2024, the Company granted 75,000 ten years 0.16 12,337 0.226 0.226 6.3 191 3.71 0 During the nine months ended October 31, 2024 and 2023, we recognized $ 300,101 38,553 As of October 31, 2024, there was $ 47,901 Warrants As of October 31, 2024, there were 14,032,073 13,524,541 1.75 0.12 1,618,975 Stock warrants outstanding at October 31, 2024 are as follows: Schedule of Stock Warrants Outstanding Number of Weighted Outstanding, January 31, 2024 14,254,813 $ 0.21 Issued – – Expired (222,740 ) 1.26 Exercised – – Outstanding, October 31, 2024 14,032,073 $ 0.19 Exercisable, October 31, 2024 13,524,541 $ 0.12

Derivative Liabilities

Derivative Liabilities	9 Months Ended
	Oct. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	NOTE 6 – Derivative Liabilities The embedded conversion feature in the convertible debt instruments that the Company issued (See Note 8), that became convertible during the nine months ended October 31, 2024, qualified it as a derivative instrument since the number of shares issuable under the note is indeterminate based on guidance in FASB ASC 815, Derivatives and Hedging The valuation of the derivative liabilities of the warrants was determined through the use of a Monte Carlo option pricing model that values the liability of the warrants based on a risk-neutral valuation where the price of the warrant is its discounted expected value. The technique applied generates a large number of possible (but random) price paths for the underlying common stock via simulation, and then calculates the associated exercise value (i.e. “payoff”) of the warrant for each path. These payoffs are then averaged and discounted to a current valuation date resulting in the fair value of the warrant. The valuation of the derivative liabilities attached to the convertible debt was arrived at through the use of a Monte Carlo model that values the derivative liability within the notes. The technique applied generates a large number of possible (but random) price paths for the underlying (or underlyings) via simulation, and then calculates the associated payment value (cash, stock, or warrants) of the derivative features. The price of the underlying common stock is modeled such that it follows a geometric Brownian motion with constant drift, and elastic volatility (increasing as stock price decreases). The stock price is determined by a random sampling from a normal distribution. Since the underlying random process is the same, for enough price paths, the value of the derivative is derived from path dependent scenarios and outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion features with the reset provisions, the call/redemption/prepayment options, and the default provisions. Based on these features, there are six primary events that can occur; payments are made in cash; payments are made with stock; the note holder converts upon receiving a redemption notice; the note holder converts the note; the issuer redeems the note; or the Company defaults on the note. The model simulates the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, conversion price, etc.). Probabilities were assigned to each variable such as redemption likelihood, default likelihood, and timing and pricing of reset events over the remaining term of the notes based on management projections. This led to a cash flow simulation over the life of the note. A discounted cash flow for each simulation was completed, and it was compared to the discounted cash flow of the note without the embedded features, thus determining a value for the derivative liabilities. Key inputs and assumptions used to value the convertible note when it became convertible and upon settlement, and warrants upon tainting, were as follows: ● The stock projections are based on the historical volatilities for each date. The volatility of 188.8 1.8 ● The Holder will exercise the warrant at maturity if the stock price was above the exercise price; ● Discount rate was based on risk free rates of 4.36 ● Dividend yield: 0 ● Exercise Price: $ 0.04 16.20 20 ● Number of Options: $ 1 ● The shares issued and outstanding is based on the initial 10,888,894 51,156,228 2.49 500,000 25 Using the results from the model, the Company recorded a derivative liability during the nine months ended October 31, 2024 of $ 67,352 0 67,352 67,352 0 During the nine months ended October 31, 2024, the Company recorded a gain of $ 3,783,056 Using the results from the model, the Company recorded a derivative liability during the nine months ended October 31, 2023 of $ 146,368 0 146,368 197,477 0 During the nine months ended October 31, 2023, the Company recorded $ 156,309 160,551 The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liabilities: Schedule of Changes in Fair value of Derivative Liabilities Nine months ended October 31, 2024 2023 Beginning balance $ 2,547,458 $ 172,393 Total gain (3,783,056 ) (160,551 ) Settlements (52,476 ) (156,309 ) Additions recognized as debt discount 67,352 146,368 Changes due to tainted (untainted) warrants 1,858,199 (1,901 ) Ending balance $ 637,477 $ - Change in fair value of derivative liabilities included in earnings relating to derivatives $ (3,783,056 ) $ (160,551 )

Long-term debt and convertible

Long-term debt and convertible promissory notes	9 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Long-term debt and convertible promissory notes	NOTE 7 – Long-term debt and convertible promissory notes Following is a summary of convertible promissory notes: Schedule of Convertible Promissory Notes October 31, January 31, 8% convertible note payable issued January 2024 October 2024 $ - $ 110,000 10% convertible note payable issued February 2024 November 2024 10,500 – 10% convertible note payable issued June 2024 March 2025 66,000 – 10% convertible note payable issued August 2024 May 2025 67,200 – 10% convertible note payable issued October 2024 July 2025 97,200 – Convertible note payable 240,900 110,000 Less debt discount (39,917 ) (15,000 ) Less current portion of convertible notes (200,983 ) (95,000 ) Long-term convertible notes payable $ – $ – On January 12, 2024, the Company entered into a convertible promissory note with 1800 Diagonal Lending in the aggregate principal amount of $ 110,000 8 10,000 5,000 March 24,2024 180 75 10 110,000 867,389 As of October 31, 2024, the note balance was $ 0 95,000 15,000 On February 23, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $ 126,000 10 21,000 5,000 November 30, 2024 65 10 115,500 7,724 2,776 On June 13, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $ 126,000 10 21,000 5,000 March 15, 2025 65 10 63,545 2,455 On August 28, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $ 67,200 10 11,200 6,000 May 30, 2025 65 10 54,003 13,197 On October 22, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $ 97,200 10 16,200 6,000 July 30, 2025 65 10 75,711 21,489 During the nine months ended October 31, 2024 and 2023, the Company recorded debt discounts of $ 67,352 146,368 70,400 17,350 112,835 197,477 Notes Payable On June 22, 2020, the Company received loan proceeds of $ 32,300 100 3.75 30 158 In April 2024, the Company entered into a Premium Finance Agreement related to an insurance policy. The policy premiums total $ 33,500 one-year policy period 24,750 2,903 13.2 As of October 31, 2024, the notes payable, net balance was $ 40,922 32,400 8,522 2,729 32,400 2,729

Commitments and contingencies

Commitments and contingencies	9 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	NOTE 8 – Commitments and contingencies We currently rent storage space for $ 105 We are required to pay annual rentals for Liberty Star’s federal lode mining claims for the Tombstone project in the State of Arizona. The rental period begins at noon on September 1 st st 200 The rentals due by September 1, 2024 15,345 We are required to pay annual rentals for our Arizona State Land Department Mineral Exploration Permits (“AZ MEP”) at our Tombstone Hay Mountain project in the State of Arizona. AZ MEP permits cost $500 per permit per year in non-refundable filing fees and are valid for 1 year and renewable for up to 5 years. 2.00 1.00 10 20 12,878.18 27,264

Subsequent Events

Subsequent Events	9 Months Ended
	Oct. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	NOTE 9 – Subsequent Events The Company has evaluated subsequent events through the filing date of this Form 10-Q and determined that the following subsequent events have occurred that would require recognition in the consolidated financial statements or disclosures in the notes thereto. On November 8, 2024, the Investor purchased 258,228 26,461 0.10 On November 22, 2024, the Investor purchased 318,322 26,884 0.09 On December 2, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $ 67,200 10% 11,200 6,000 September 15, 2025 the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. On December 11, 2024, the Investor purchased 213,135 12,675 0.067

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Fair Value	Fair Value Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) ASC 820 Fair Value Measurements and Disclosures Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services. Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort. Schedule of Fair Value of Financial Instruments Fair value measurements at reporting date using: Description Fair Value Quoted Significant Significant Warrant and convertible note derivative liabilities at October 31, 2024 $ 637,477 – – $ 637,477 Warrant and convertible note derivative liabilities at January 31, 2024 $ 2,547,458 – – $ 2,547,458 Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liabilities. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liabilities, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liabilities are reported in other income (expense) as gain (loss) on change in fair value of derivative liabilities.
Net income (loss) per share	Net income (loss) per share Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Potential common stock equivalents are determined using the treasury stock method. For diluted net income (loss) per share purposes, the Company excludes stock options and other stock-based awards, including shares issued as a result of option exercises that are subject to repurchase by the Company, whose effect would be anti-dilutive from the calculation. During the three and nine months ended October 31, 2024, the impact of 1,525,386 1,743,667 9,281,827 10,412,006 0 0 2,099,941 3,450,319 A reconciliation of the weighted average shares outstanding used in basic and diluted earnings per share computation is as follows: Schedule of Reconciliation of Weighted Average Shares Outstanding 2024 2023 2024 2023 For the Three Months Ended For the Nine Months Ended October 31, October 31, 2024 2023 2024 2023 Basic income (loss) per common share Net income (loss) available to common shareholders $ 926,992 $ (252,609 ) $ 2,387,518 $ (574,567 ) Derivative (gain) loss associated with convertible debt (11,432 ) - (14,876 ) - Interest expense associated with convertible debt (5,142 ) - (16,415 ) - Net income (loss) for dilutive calculation $ 910,418 $ (252,609 ) $ 2,356,227 $ (574,567 ) Weighted average common shares outstanding 50,794,090 32,289,211 50,193,594 24,676,301 Dilutive effect of convertible debt - - - - Dilutive effect of common stock warrants 9,281,827 - 10,412,006 - Dilutive effect of common stock options 1,525,386 - 1,743,667 - Weighted average shares outstanding for diluted net income (loss) per share 61,601,303 32,289,211 62,349,267 24,676,301

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Schedule of Fair Value of Financial Instruments	Schedule of Fair Value of Financial Instruments Fair value measurements at reporting date using: Description Fair Value Quoted Significant Significant Warrant and convertible note derivative liabilities at October 31, 2024 $ 637,477 – – $ 637,477 Warrant and convertible note derivative liabilities at January 31, 2024 $ 2,547,458 – – $ 2,547,458
Schedule of Reconciliation of Weighted Average Shares Outstanding	A reconciliation of the weighted average shares outstanding used in basic and diluted earnings per share computation is as follows: Schedule of Reconciliation of Weighted Average Shares Outstanding 2024 2023 2024 2023 For the Three Months Ended For the Nine Months Ended October 31, October 31, 2024 2023 2024 2023 Basic income (loss) per common share Net income (loss) available to common shareholders $ 926,992 $ (252,609 ) $ 2,387,518 $ (574,567 ) Derivative (gain) loss associated with convertible debt (11,432 ) - (14,876 ) - Interest expense associated with convertible debt (5,142 ) - (16,415 ) - Net income (loss) for dilutive calculation $ 910,418 $ (252,609 ) $ 2,356,227 $ (574,567 ) Weighted average common shares outstanding 50,794,090 32,289,211 50,193,594 24,676,301 Dilutive effect of convertible debt - - - - Dilutive effect of common stock warrants 9,281,827 - 10,412,006 - Dilutive effect of common stock options 1,525,386 - 1,743,667 - Weighted average shares outstanding for diluted net income (loss) per share 61,601,303 32,289,211 62,349,267 24,676,301

Stockholders_ deficit (Tables)

Stockholders’ deficit (Tables)	9 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	Qualified and non-qualified incentive stock options outstanding at October 31, 2024 are as follows: Schedule of Stock Option Activity Number of Weighted Outstanding, January 31, 2024 2,808,760 $ 0.83 Granted 632,238 0.22 Expired – – Exercised (75,000 ) 0.05 Outstanding, October 31, 2024 3,365,998 $ 0.74 Exercisable, October 31, 2024 3,203,498 $ 0.76
Schedule of Stock Warrants Outstanding	Stock warrants outstanding at October 31, 2024 are as follows: Schedule of Stock Warrants Outstanding Number of Weighted Outstanding, January 31, 2024 14,254,813 $ 0.21 Issued – – Expired (222,740 ) 1.26 Exercised – – Outstanding, October 31, 2024 14,032,073 $ 0.19 Exercisable, October 31, 2024 13,524,541 $ 0.12

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	9 Months Ended
	Oct. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Changes in Fair value of Derivative Liabilities	The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liabilities: Schedule of Changes in Fair value of Derivative Liabilities Nine months ended October 31, 2024 2023 Beginning balance $ 2,547,458 $ 172,393 Total gain (3,783,056 ) (160,551 ) Settlements (52,476 ) (156,309 ) Additions recognized as debt discount 67,352 146,368 Changes due to tainted (untainted) warrants 1,858,199 (1,901 ) Ending balance $ 637,477 $ - Change in fair value of derivative liabilities included in earnings relating to derivatives $ (3,783,056 ) $ (160,551 )

Long-term debt and convertibl_2

Long-term debt and convertible promissory notes (Tables)	9 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Schedule of Convertible Promissory Notes	Following is a summary of convertible promissory notes: Schedule of Convertible Promissory Notes October 31, January 31, 8% convertible note payable issued January 2024 October 2024 $ - $ 110,000 10% convertible note payable issued February 2024 November 2024 10,500 – 10% convertible note payable issued June 2024 March 2025 66,000 – 10% convertible note payable issued August 2024 May 2025 67,200 – 10% convertible note payable issued October 2024 July 2025 97,200 – Convertible note payable 240,900 110,000 Less debt discount (39,917 ) (15,000 ) Less current portion of convertible notes (200,983 ) (95,000 ) Long-term convertible notes payable $ – $ –

Schedule of Fair Value of Finan

Schedule of Fair Value of Financial Instruments (Details) - USD ($)	Oct. 31, 2024	Jan. 31, 2024
Platform Operator, Crypto Asset [Line Items]
Warrant and convertible note derivative liabilities	$ 637,477	$ 2,547,458
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto Asset [Line Items]
Warrant and convertible note derivative liabilities
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto Asset [Line Items]
Warrant and convertible note derivative liabilities
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto Asset [Line Items]
Warrant and convertible note derivative liabilities	$ 637,477	$ 2,547,458

Schedule of Reconciliation of W

Schedule of Reconciliation of Weighted Average Shares Outstanding (Details) - USD ($)	3 Months Ended						9 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Apr. 30, 2024	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2024	Oct. 31, 2023
Accounting Policies [Abstract]
Net income ( loss)	$ 926,992	$ 1,149,145	$ 311,381	$ (252,609)	$ (203,379)	$ (118,579)	$ 2,387,518	$ (574,567)
Derivative (gain) loss associated with convertible debt	(11,432)						(14,876)
Interest expense associated with convertible debt	(5,142)						(16,415)
Net income (loss) for dilutive calculation	$ 910,418			$ (252,609)			$ 2,356,227	$ (574,567)
Weighted average common shares outstanding	50,794,090			32,289,211			50,193,594	24,676,301
Dilutive effect of convertible debt
Dilutive effect of common stock warrants	9,281,827						10,412,006
Dilutive effect of common stock options	1,525,386						1,743,667
Weighted average shares outstanding for diluted net income (loss) per share	61,601,303			32,289,211			62,349,267	24,676,301

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - shares	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive effects impact of stock options	1,525,386		1,743,667
Dilutive effects impact of warrants	9,281,827		10,412,006
Dilutive effect of convertible debt
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive effects impact of warrants		0		0
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive effects impact of warrants		2,099,941		3,450,319

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)

9 Months Ended

12 Months Ended

Aug. 23, 2024

Jul. 05, 2024

Jun. 28, 2024

May 20, 2024

May 01, 2024

Apr. 03, 2024

Feb. 21, 2024

Feb. 13, 2024

Jan. 25, 2024

Mar. 13, 2023

Oct. 31, 2024

Oct. 31, 2023

Jan. 31, 2024

Feb. 12, 2024

Jan. 31, 2023

Related Party Transaction [Line Items]

Advances from chairman

$ 467,000

$ 35,000

Related party debt paid

$ 25,000

Stock options exercised

75,000

Shares issued during option exercise

70,002

75,000

Number of options, granted

632,238

Weighted average exercise price per share, granted

$ 0.22

Fair value stock price

$ 0.226

$ 0.226

$ 0.178

Exercise price

$ 0.226

$ 0.226

Term

6 years 3 months 18 days

10 years

Volatility

191%

178%

Discount rate, minimum

3.71%

4.36%

Dividend yield

0%

0%

Chairman [Member]

Related Party Transaction [Line Items]

Advances from chairman

$ 210,000

Related party debt paid

25,000

Board of Directors [Member]

Related Party Transaction [Line Items]

Number of options, granted

337,501

Options expiration period

10 years

Weighted average exercise price per share, granted

$ 0.226

Total fair value of options vested upon issuance

$ 76,275

Patricia Madaris [Member]

Related Party Transaction [Line Items]

Accrued unpaid vacation

8,117

$ 0

Related Party [Member]

Related Party Transaction [Line Items]

Advance related party balance

185,000

Promissory note, face value

$ 70,000

$ 67,000

$ 45,000

$ 75,000

$ 210,000

Interest rate

10%

10%

10%

10%

10%

Maturity date

Jul. 05, 2025

May 20, 2025

May 01, 2025

Apr. 03, 2025

Feb. 13, 2025

Notes payable to related party

736,598

326,828

Brett Gross [Member]

Related Party Transaction [Line Items]

Related party debt paid

40,000

Promissory note, face value

$ 50,000

Increase in promissory note

$ 86,579

Interest rate

10%

Maturity date

Jan. 31, 2024

Recourse loan

$ 16,750

Accrued interest

$ 480

Notes payable to related party

$ 19,598

$ 76,828

Number of options, granted

250,000

Options expiration period

10 years

Director [Member]

Related Party Transaction [Line Items]

Promissory note, face value

$ 250,000

Interest rate

10%

Maturity date

Jan. 25, 2025

Schedule of Stock Option Activi

Schedule of Stock Option Activity (Details) - $ / shares		9 Months Ended
	Feb. 21, 2024	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Number of options, outstanding beginning		2,808,760
Weighted average exercise price per share, outstanding beginning		$ 0.83
Number of options, granted		632,238
Weighted average exercise price per share, granted		$ 0.22
Number of options, expired
Weighted average exercise price per share, expired
Number of options, exercised	(70,002)	(75,000)
Weighted average exercise price, Exercised		$ 0.05
Number of options, outstanding ending		3,365,998
Weighted average exercise price per share, outstanding ending		$ 0.74
Number of options, exercisable		3,203,498
Weighted average exercise price per share, exercisable		$ 0.76

Schedule of Stock Warrants Outs

Schedule of Stock Warrants Outstanding (Details) - Warrant [Member]	9 Months Ended
	Oct. 31, 2024 $ / shares shares
Number of warrants, Outstanding | shares	14,254,813
Weighted average exercise price per share, Outstanding | $ / shares	$ 0.21
Number of warrants, Issued | shares
Weighted average exercise price per share, Issued | $ / shares
Number of warrants, Expired | shares	(222,740)
Weighted average exercise price per share, Expired | $ / shares	$ 1.26
Number of warrants, Exercised | shares
Weighted average exercise price per share, Exercised | $ / shares
Number of warrants, Outstanding | shares	14,032,073
Weighted average exercise price per share, Outstanding | $ / shares	$ 0.19
Number of warrants, Exercisable | shares	13,524,541
Weighted average exercise price per share, Exercisable | $ / shares	$ 0.12

Stockholders_ deficit (Details

Stockholders’ deficit (Details Narrative) - USD ($)

3 Months Ended

9 Months Ended

12 Months Ended

Oct. 24, 2024

Sep. 25, 2024

Aug. 23, 2024

Aug. 05, 2024

Jun. 28, 2024

Feb. 21, 2024

Feb. 12, 2024

Dec. 04, 2023

May 26, 2023

Mar. 13, 2023

Sep. 29, 2022

Oct. 31, 2024

Jul. 31, 2024

Apr. 30, 2024

Oct. 31, 2023

Jul. 31, 2023

Apr. 30, 2023

Oct. 31, 2024

Oct. 31, 2023

Jan. 31, 2024

Jul. 03, 2024

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Common stock shares authorized

149,500,000

149,500,000

149,500,000

75,000,000

Issuance of stock, value

$ 6,414

Net proceeds of common stock

$ 6,414

Number of options, granted

632,238

Exercise price

$ 0.74

$ 0.74

$ 0.83

Option exercised, value

Option exercised, shares

70,002

75,000

Subscription receivable

16,750

Subscription receivable

$ 101,100

$ 101,100

$ 117,850

Options, weighted average remaining life

9 years 1 month 9 days

Options, aggregate intrinsic value

$ 253,984

$ 253,984

Fair value stock price

$ 0.226

$ 0.226

$ 0.178

$ 0.178

Weighted average exercise price per share, granted

$ 0.22

Stock options, compensation expense

$ 357,330

63,243

Fair value exercise price

$ 0.226

$ 0.226

Fair value term

6 years 3 months 18 days

10 years

Fair value volatility

191%

178%

Fair value discount rate

3.71%

4.36%

Fair value dividend yield

0%

0%

Unrecognized share-based compensation

$ 47,901

$ 47,901

Purchase warrants outstanding

14,032,073

14,032,073

Purchase warrants exercisable

13,524,541

13,524,541

Warrants weighted average remaining life

1 year 9 months

1 year 9 months

Weighted average exercise price of warrant

$ 0.12

$ 0.12

Aggregate intrinsic value

$ 1,618,975

$ 1,618,975

Brett Gross [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of options, granted

250,000

Options expiration period

10 years

Exercise price

$ 0.067

Fair value of option granted

$ 16,750

Interest rate

10%

Maturity date

Jan. 31, 2024

Subscription receivable

$ 16,750

Accrued interest

$ 480

Officers Employees and Consultants [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Stock options, compensation expense

300,101

$ 38,553

Common Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Issuance of stock

79,976

Issuance of stock, value

$ 1

Net proceeds of common stock

$ 500,000

Shares of common stock for conversions

682,008

185,381

2,725,574

1,690,073

1,251,270

867,389

Shares of common stock for conversions, value

$ 110,000

Interest on convertible notes payable

$ 4,000

Option exercised, value

$ 1

$ 3

Option exercised, shares

70,002

250,000

Subscription receivable

Common Stock [Member] | Maximum [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Common stock conversion price

$ 0.1888

$ 0.1888

Common Stock [Member] | Minimum [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Common stock conversion price

$ 0.0961

$ 0.0961

Other Additional Capital [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Deferred offering cost

$ 1,000

$ 1,000

Investment Agreement [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Unamortized deferred offering cost

$ 20,000

$ 20,000

Investment Agreement [Member] | Investor [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Issuance of stock

100,000

Issuance of stock, value

$ 20,000

Sale of stock description

The amount that we shall be entitled to sell to Investor shall be equal to two hundred percent (200%) of the average daily volume (U.S. market only) of the common stock for the ten (10) trading days prior to the applicable notice date so long as such amount does not exceed a calculated dollar amount per every 10 days of $500,000. The minimum amount shall be equal to $10,000.

Investment Agreement [Member] | Investor [Member] | Maximum [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares purchased

10,000,000

Note Agreements [Member] | Brett Gross [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Option exercised, value

$ 16,750

Option exercised, shares

250,000

Interest rate

3.15%

Maturity date

Mar. 15, 2028

Investor [Member] | Stock Compensation And Subscription Agreement [Member] | Common Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Share based compensation

$ 45,000

$ 12,229

Employees [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of options, granted

674,000

Options expiration period

10 years

Exercise price

$ 0.15

Fair value of option granted

$ 104,226

Employees [Member] | Note Agreements [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Option exercised, value

$ 101,100

Option exercised, shares

674,000

Interest rate

3.15%

Maturity date

Sep. 30, 2027

Geologist [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Options expiration period

3 years

Compensation per month

$ 4,000

Options granted

10,000

54,000

Stock options grants per month

4,000

Fair value of options granted

$ 15,024

Stock options, compensation expense

$ 15,024

Geologist [Member] | Maximum [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Weighted average exercise price per share, granted

$ 0.725

Geologist [Member] | Minimum [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Weighted average exercise price per share, granted

$ 0.047

Employee [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of options, granted

165,737

Options expiration period

10 years

Weighted average exercise price per share, granted

$ 0.226

Total fair value of options vested upon issuance

$ 37,457

Board [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of options, granted

75,000

Options expiration period

10 years

Weighted average exercise price per share, granted

$ 0.16

Total fair value of options vested upon issuance

$ 12,337

Restricted Stock [Member] | Investment Agreement [Member] | Investor [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares purchased

79,976

Net proceeds of common stock

$ 6,414

Share price per share

$ 0.08

$ 0.08

Restricted Stock [Member] | Investor [Member] | Stock Compensation And Subscription Agreement [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Issuance of stock

225,000

978,300

Issuance of stock, value

$ 45,000

Schedule of Changes in Fair val

Schedule of Changes in Fair value of Derivative Liabilities (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Beginning balance			$ 2,547,458	$ 172,393
Total gains			(3,783,056)	(160,551)
Settlements			(52,476)	(156,309)
Additions recognized as debt discount			67,352	146,368
Additions due to tainted warrants			1,858,199	(1,901)
Ending balance	$ 637,477		637,477
Change in fair value of derivative liabilities included in earnings relating to derivatives	$ (1,289,458)	$ (86,112)	$ (3,783,056)	$ (160,551)

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative)	3 Months Ended		9 Months Ended
	Oct. 31, 2024 USD ($) $ / shares shares	Oct. 31, 2023 USD ($)	Oct. 31, 2024 USD ($) $ / shares shares	Oct. 31, 2023 USD ($)	Jan. 31, 2024 shares	Oct. 31, 2021 shares
Derivative [Line Items]
Common stock, shares outstanding | shares	51,156,228		51,156,228		49,813,861	10,888,894
Common stock, shares issued | shares	51,156,228		51,156,228		49,813,861
Common stock shares growth monthly percentage	2.49%		2.49%
Proceeds from sale of common stock			$ 6,414
Amortization of debt discount			112,835	197,477
Gain on derivative liabilities	$ 1,289,458	$ 86,112	3,783,056	160,551
Reclassification due to conversion of convertible notes				156,309
Derivative Liability [Member]
Derivative [Line Items]
Derivative loss			0	0
Amortization of debt discount			67,352	146,368
Interest expense			67,352	197,477
Unamortized debt discount	0	0	0	0
Derivative Liability [Member] | Convertible Debt [Member]
Derivative [Line Items]
Derivative liabilities	$ 67,352	$ 146,368	67,352	$ 146,368
Common Stock [Member]
Derivative [Line Items]
Proceeds from sale of common stock			$ 500,000
Common stock, discount percentage	25%		25%
Measurement Input, Price Volatility [Member]
Derivative [Line Items]
Derivative liabilities, measurement input	188.8		188.8
Measurement Input, Expected Term [Member]
Derivative [Line Items]
Expected term	1 year 9 months 18 days		1 year 9 months 18 days
Measurement Input, Risk Free Interest Rate [Member]
Derivative [Line Items]
Derivative liabilities, measurement input	4.36		4.36
Measurement Input, Expected Dividend Rate [Member]
Derivative [Line Items]
Derivative liabilities, measurement input	0		0
Measurement Input, Exercise Price [Member]
Derivative [Line Items]
Derivative liabilities, measurement input | $ / shares	20		20
Measurement Input, Exercise Price [Member] | Share-Based Payment Arrangement, Option [Member]
Derivative [Line Items]
Derivative liabilities, measurement input | $ / shares	1		1
Measurement Input, Exercise Price [Member] | Minimum [Member]
Derivative [Line Items]
Derivative liability exercise price | $ / shares	$ 0.04		$ 0.04
Measurement Input, Exercise Price [Member] | Maximum [Member]
Derivative [Line Items]
Derivative liability exercise price | $ / shares	$ 16.20		$ 16.20

Schedule of Convertible Promiss

Schedule of Convertible Promissory Notes (Details) - USD ($)	Oct. 31, 2024	Jan. 31, 2024
Short-Term Debt [Line Items]
Convertible note payable	$ 240,900	$ 110,000
Less debt discount	(39,917)	(15,000)
Less current portion of convertible notes	(200,983)	(95,000)
Long-term convertible notes payable
January 2024 Note [Member]
Short-Term Debt [Line Items]
Convertible note payable		110,000
February 2024 Note [Member]
Short-Term Debt [Line Items]
Convertible note payable	10,500
June 2024 Note [Member]
Short-Term Debt [Line Items]
Convertible note payable	66,000
August 2024 Note [Member]
Short-Term Debt [Line Items]
Convertible note payable	67,200
October 2024 Note [Member]
Short-Term Debt [Line Items]
Convertible note payable	$ 97,200

Summary of Convertible Promisso

Summary of Convertible Promissory Notes (Details) (Parenthetical)	9 Months Ended
	Oct. 31, 2024
January 2024 Note [Member]
Short-Term Debt [Line Items]
Notes issuance date	2024-01
Notes maturity period	2024-10
February 2024 Note [Member]
Short-Term Debt [Line Items]
Notes issuance date	2024-02
Notes maturity period	2024-11
June 2024 Note [Member]
Short-Term Debt [Line Items]
Notes issuance date	2024-06
Notes maturity period	2025-03
August 2024 Note [Member]
Short-Term Debt [Line Items]
Notes issuance date	2024-08
Notes maturity period	2025-05
October 2024 Note [Member]
Short-Term Debt [Line Items]
Notes issuance date	2024-10
Notes maturity period	2025-07

Long-term debt and convertibl_3

Long-term debt and convertible promissory notes (Details Narrative)							1 Months Ended	9 Months Ended		12 Months Ended
	Oct. 22, 2024 USD ($) Integer	Aug. 28, 2024 USD ($) Integer	Jun. 13, 2024 USD ($) Integer	Feb. 23, 2024 USD ($) Integer	Jan. 12, 2024 USD ($) Integer	Jun. 22, 2020 USD ($)	Apr. 30, 2024 USD ($)	Oct. 31, 2024 USD ($) shares	Oct. 31, 2023 USD ($)	Jan. 31, 2024 USD ($)
Short-Term Debt [Line Items]
Debt discount								$ 67,352	$ 146,368
Original issue debt discounts and fees paid								70,400	17,350
Amortization of debt discount								112,835	$ 197,477
Note principal balance								40,922		$ 32,400
Long term payable								32,400		32,400
Current portion of notes payable								8,522
Accured interest								2,729		2,729
SBA's Economic Injury Disaster Loan Program [Member]
Short-Term Debt [Line Items]
Fee amount						$ 100
Proceeds from loans originations						$ 32,300
Line of credit facility interest rate during period						3.75%
Debt instrument term						30 years
Debt instrument periodic payment						$ 158
Premium Finance Agreement [Member]
Short-Term Debt [Line Items]
Interest rate, percentage							13.20%
Debt instrument periodic payment							$ 2,903
Insurance policy premiums							$ 33,500
Insurance policy premiums description							one-year policy period
Insurance financed							$ 24,750
January 2024 Note [Member]
Short-Term Debt [Line Items]
Debt instrument, face value					$ 110,000
Interest rate, percentage					8%
Original issue discount					$ 10,000					15,000
Fee amount					$ 5,000
Debt instrument, maturity date					Mar. 24, 2024
Debt instrument convertible consecutive trading days | Integer					180
Common stock conversion, percentage					75%
Debt instrument, convertible, threshold trading days | Integer					10
Debt instrument conversion, amount								$ 110,000
Debt conversion on convertible shares | shares								867,389
Note balance								$ 0		$ 95,000
February 2024 Note [Member]
Short-Term Debt [Line Items]
Debt instrument, face value				$ 126,000
Interest rate, percentage				10%
Original issue discount				$ 21,000				2,776
Fee amount				$ 5,000
Debt instrument, maturity date				Nov. 30, 2024
Common stock conversion, percentage				65%
Debt instrument, convertible, threshold trading days | Integer				10
Note balance								7,724
Repayment of notes								115,500
June 2024 Note [Member]
Short-Term Debt [Line Items]
Debt instrument, face value			$ 126,000
Interest rate, percentage			10%
Original issue discount			$ 21,000					2,455
Fee amount			$ 5,000
Debt instrument, maturity date			Mar. 15, 2025
Common stock conversion, percentage			65%
Debt instrument, convertible, threshold trading days | Integer			10
Note balance								63,545
August 2024 Note [Member]
Short-Term Debt [Line Items]
Debt instrument, face value		$ 67,200
Interest rate, percentage		10%
Original issue discount		$ 11,200						13,197
Fee amount		$ 6,000
Debt instrument, maturity date		May 30, 2025
Common stock conversion, percentage		65%
Debt instrument, convertible, threshold trading days | Integer		10
Note balance								54,003
October 2024 Note [Member]
Short-Term Debt [Line Items]
Debt instrument, face value	$ 97,200
Interest rate, percentage	10%
Original issue discount	$ 16,200							21,489
Fee amount	$ 6,000
Debt instrument, maturity date	Jul. 30, 2025
Common stock conversion, percentage	65%
Debt instrument, convertible, threshold trading days | Integer	10
Note balance								$ 75,711

Commitments and contingencies (

Commitments and contingencies (Details Narrative)	9 Months Ended
	Oct. 31, 2024 USD ($) a $ / shares	Oct. 31, 2025 USD ($)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Payments for rent	$ 200
Lease due date	Sep. 01, 2024
AZMEP [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Project validity description	AZ MEP permits cost $500 per permit per year in non-refundable filing fees and are valid for 1 year and renewable for up to 5 years.
AZMEP [Member] | Phase One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Minimum work expenditure requirements	$ 27,264
AZMEP [Member] | First Year [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Rental fee per acre | $ / shares	$ 2
AZMEP [Member] | Three Through Five Year [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Rental fee per acre | $ / shares	$ 1
Minimum work expenditure requirements	$ 20
AZMEP [Member] | One and Two Years [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Minimum work expenditure requirements	$ 10
Tombstone Project [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Project validity description	The rentals due by September 1, 2024 for the period from September 1, 2024 through September 1, 2025 of $15,345 have been paid.
Area of land | a	12,878.18
Tombstone Project [Member] | Forecast [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Accrued rent		$ 15,345
Tombstone Region of Arizona [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Payments for rent	$ 105

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)					9 Months Ended
	Dec. 11, 2024	Dec. 02, 2024	Nov. 22, 2024	Nov. 08, 2024	Oct. 31, 2024	Oct. 31, 2023	Aug. 23, 2024	Jun. 28, 2024
Subsequent Event [Line Items]
Proceeds from the issuance of common stock for cash, net					$ 6,414
Share price per share					$ 0.178		$ 0.226	$ 0.226
Subsequent Event [Member]
Subsequent Event [Line Items]
Aggregate principal amount		$ 67,200
Note bears interest percent		10%
Original issue discount		$ 11,200
Pay for transaction fees of lender		$ 6,000
Debt maturity date		Sep. 15, 2025
Note convertible into shares description		the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion.
Subsequent Event [Member] | Restricted Stock [Member] | Investor [Member]
Subsequent Event [Line Items]
Shares issued	213,135		318,322	258,228
Proceeds from the issuance of common stock for cash, net	$ 12,675		$ 26,884	$ 26,461
Share price per share	$ 0.067		$ 0.09	$ 0.10